Jennifer J. Knox, MD, FRCPC, on RASolute 302 Findings: Expert Point of View

June 01, 2026 By The ASCO Post Staff

Jennifer J. Knox, MD, FRCPC, of Princess Margaret Cancer Centre, provides expert commentary on a phase III study of daraxonrasib vs chemotherapy in previously treated metastatic pancreatic cancer (Abstract LBA5).

Related Content